199 related articles for article (PubMed ID: 24215565)
1. Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China.
Liu H; Yang HL; Xu JW; Wang JZ; Nie RH; Li CF
Malar J; 2013 Nov; 12():409. PubMed ID: 24215565
[TBL] [Abstract][Full Text] [Related]
2. Artemisinin-naphthoquine combination (ARCO) therapy for uncomplicated falciparum malaria in adults of Papua New Guinea: a preliminary report on safety and efficacy.
Hombhanje FW; Linge D; Saweri A; Kuanch C; Jones R; Toraso S; Geita J; Masta A; Kevau I; Hiawalyer G; Sapuri M
Malar J; 2009 Aug; 8():196. PubMed ID: 19671190
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
4. Monitoring the Efficacy of Chloroquine-Primaquine Therapy for Uncomplicated Plasmodium vivax Malaria in the Main Transmission Hot Spot of Brazil.
Ladeia-Andrade S; Menezes MJ; de Sousa TN; Silvino ACR; de Carvalho JF; Salla LC; Nery OA; de Melo GNP; Corder RM; Rodrigues PT; Ferreira MU
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782991
[TBL] [Abstract][Full Text] [Related]
5. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
Abreha T; Hwang J; Thriemer K; Tadesse Y; Girma S; Melaku Z; Assef A; Kassa M; Chatfield MD; Landman KZ; Chenet SM; Lucchi NW; Udhayakumar V; Zhou Z; Shi YP; Kachur SP; Jima D; Kebede A; Solomon H; Mekasha A; Alemayehu BH; Malone JL; Dissanayake G; Teka H; Auburn S; von Seidlein L; Price RN
PLoS Med; 2017 May; 14(5):e1002299. PubMed ID: 28510573
[TBL] [Abstract][Full Text] [Related]
6. Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.
Awab GR; Imwong M; Bancone G; Jeeyapant A; Day NPJ; White NJ; Woodrow CJ
Am J Trop Med Hyg; 2017 Dec; 97(6):1782-1787. PubMed ID: 29141719
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
[TBL] [Abstract][Full Text] [Related]
8. Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trial.
Liu H; Xu JW; Deng DW; Yaw B; Nbwi HS; Wei C; Zhou XW; Li JX
Parasit Vectors; 2024 Jan; 17(1):28. PubMed ID: 38254128
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal.
Rijal KR; Adhikari B; Ghimire P; Banjara MR; Das Thakur G; Hanboonkunupakarn B; Imwong M; Chotivanich K; Day NPJ; White NJ; Pukrittayakamee S
J Infect Dis; 2019 Jul; 220(3):448-456. PubMed ID: 30882150
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.
Yuan L; Wang Y; Parker DM; Gupta B; Yang Z; Liu H; Fan Q; Cao Y; Xiao Y; Lee MC; Zhou G; Yan G; Baird JK; Cui L
Antimicrob Agents Chemother; 2015 Feb; 59(2):1230-5. PubMed ID: 25512415
[TBL] [Abstract][Full Text] [Related]
11. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
Warrasak S; Euswas A; Fukuda MM; Ittiverakul M; Miller RS; Krudsood S; Ohrt C
Int Ophthalmol; 2019 Aug; 39(8):1767-1782. PubMed ID: 30269312
[TBL] [Abstract][Full Text] [Related]
12. Blood stage of Plasmodium vivax in central China is still susceptible to chloroquine plus primaquine combination therapy.
Zhu G; Lu F; Cao J; Zhou H; Liu Y; Han ET; Gao Q
Am J Trop Med Hyg; 2013 Jul; 89(1):184-7. PubMed ID: 23669232
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
14. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of dihydroartemisinin-piperaquine and artesunate-amodiaquine combined with primaquine for radical treatment of vivax malaria in Sumatera, Indonesia.
Pasaribu AP; Chokejindachai W; Sirivichayakul C; Tanomsing N; Chavez I; Tjitra E; Pasaribu S; Imwong M; White NJ; Dondorp AM
J Infect Dis; 2013 Dec; 208(11):1906-13. PubMed ID: 23926329
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia.
Nelwan EJ; Ekawati LL; Tjahjono B; Setiabudy R; Sutanto I; Chand K; Ekasari T; Djoko D; Basri H; Taylor WR; Duparc S; Subekti D; Elyazar I; Noviyanti R; Sudoyo H; Baird JK
BMC Med; 2015 Dec; 13():294. PubMed ID: 26654101
[TBL] [Abstract][Full Text] [Related]
17. Fixed-Dose Artesunate-Amodiaquine Combination vs Chloroquine for Treatment of Uncomplicated Blood Stage P. vivax Infection in the Brazilian Amazon: An Open-Label Randomized, Controlled Trial.
Siqueira AM; Alencar AC; Melo GC; Magalhaes BL; Machado K; Alencar Filho AC; Kuehn A; Marques MM; Manso MC; Felger I; Vieira JL; Lameyre V; Daniel-Ribeiro CT; Lacerda MV
Clin Infect Dis; 2017 Jan; 64(2):166-174. PubMed ID: 27988484
[TBL] [Abstract][Full Text] [Related]
18. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
Corder RM; de Lima ACP; Khoury DS; Docken SS; Davenport MP; Ferreira MU
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008526. PubMed ID: 32735631
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of artemisinin-based combination therapy and chloroquine with concomitant primaquine to treat Plasmodium vivax malaria in Brazil: an open label randomized clinical trial.
Daher A; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves de Lima E Silva JC; Tada M; Ruffato R; Maia I; Dos Santos TC; Marchesini P; Santelli AC; Lalloo DG
Malar J; 2018 Jan; 17(1):45. PubMed ID: 29361939
[TBL] [Abstract][Full Text] [Related]
20. Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan.
Wangchuk S; Drukpa T; Penjor K; Peldon T; Dorjey Y; Dorji K; Chhetri V; Trimarsanto H; To S; Murphy A; von Seidlein L; Price RN; Thriemer K; Auburn S
Malar J; 2016 May; 15(1):277. PubMed ID: 27176722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
